Physician profile
Eric P Amy
NPI 1649294398
$2,446.97
in general payments reported to CMS, 2019-2025
12 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,966 · 2021: $11.90 · 2022: $47.95 · 2023: $136 · 2024: $23.71 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402 · Travel and Lodging: $19.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.90 |
| Travel and Lodging | $19.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,013.22 | 2019-2023 | Da Vinci Surgical System |
| Thd America, INC. | $157.00 | 2025 | |
| Endogastric Solutions, INC | $54.29 | 2022-2023 | Esophyx |
| Braintree Laboratories, INC. | $46.47 | 2023-2025 | Suflave, Sutab |
| Ethicon US, LLC | $40.29 | 2019-2023 | Megadyne |
| Kerecis Limited | $23.71 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Pacira Pharmaceuticals Incorporated | $22.60 | 2025 | Exparel |
| Kci USA, INC. | $20.80 | 2022 | |
| Teleflex LLC | $20.04 | 2025 | Weck |
| Reprise Biomedical, INC. | $18.60 | 2025 | Miro3d |
| Coloplast Corp | $18.05 | 2025 | |
| Innocoll Pharmaceuticals Limited | $11.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Amy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.